Closing Stock Market SummaryThe stock market closed mixed on Wednesday, as investors digested the second rate cut from the Fed this year and an earnings warning from FedEx (FDX 150.91, -22.39, -12.9%). The S&P 500 (+0.03%), Dow Jones Industrial Average (+0.1%), and Nasdaq Composite (-0.1%) finished little changed. The Russell 2000 declined 0.6%.
The FOMC voted 7-3 to cut the target range for the fed funds rate by 25 basis points to 1.75-2.00%, as expected. Price action leading up to the decision was muted and volatility quickly ensued after the policy directive. Buying conviction, however, was largely absent before and immediately after the decision as the market extended losses heading into Fed Chair Powell's press conference.
Key takeaways from the Fed's policy decision included:
(1) Voting members remained divided: St. Louis Fed President Bullard preferred a 50-basis points cut, while Boston Fed President Rosengren and Kansas City Fed President George preferred no change in the fed funds rate; (2) the median Fed member is suggesting there will be no more rate cuts in 2019 and 2020; and (3) the interest paid on excess reserve balances was lowered to 1.80% from 2.10% -- which could provide some stability in the repo market after the New York Fed injected more liquidity today.
Selling pressure soon abated and stocks climbed to session highs, with the S&P 500 financials sector (+0.4%) providing influential leadership, as the Fed Chair Powell wrapped up his press conference. The utilities sector (+0.5%) outperformed, while the energy sector (-0.4%) underperformed as oil prices ($58.07/bbl, -1.30, -2.2%) continued to pull back.
Mr. Powell said the Fed does not see a recession, is not interested in negative rates, and the repo issue has no implications for the economy or monetary policy. FedEx (FDX), meanwhile, provided a pessimistic view on the global economy. The company cut its FY20 EPS guidance due to a weakening global environment, driven by trade tensions and policy uncertainty.
On a related note, Adobe Systems (ADBE 279.72, -4.97, -1.8%) guided Q4 EPS and revenue below consensus, although it did beat earnings estimates.
The U.S. Treasury yield curve saw some flattening activity following the Fed decision. The 2-yr yield increased two basis points to 1.75%, and the 10-yr yield declined three basis points to 1.79%. The U.S. Dollar Index also strengthened after the decision, increasing 0.3% to 98.55.
Reviewing Wednesday's economic data, which included Housing Starts and Building Permits for August and the weekly MBA Mortgage Applications Index:
- Total housing starts surged 12.3% m/m in August to a seasonally adjusted annual rate of 1.364 million units (consensus 1.255 million) while total permits jumped 7.7% to 1.419 million (consensus 1.300 million).
- The key takeaway from the report is that the growth wasn't entirely a multi-unit story. Single-family starts and permits both increased nicely month-over-month. The permits increase is especially notable, because that is a leading indicator that should support the market's improved attitude toward the U.S. growth outlook.
- The weekly MBA Mortgage Applications Index declined 0.1% following a 2.0% increase in the prior week.
Looking ahead, investors will receive the following data on Friday: Existing Home Sales for August, weekly Initial and Continuing Claims, the Current Account Balance for Q2, the Philadelphia Fed Index for September, and the Conference Board's Leading Economic Index for August.
- Nasdaq Composite +23.2% YTD
- S&P 500 +19.9% YTD
- Dow Jones Industrial Average +16.4% YTD
- Russell 2000 +16.3% YTD
Gapping down
In reaction to disappointing earnings/guidance:
- FDX -10.7%, CHWY -4%, ADBE -2.7%, GIS -1.9%, STLD -1.3%
Other news:
- TBIO -10.4% (prices offering of 9 mln shares of its common stock at a public offering price of $10.00 per share)
- PTCT -7.9% (commences public offering of $100 mln of shares of common stock and $250 mln convertible senior notes due 2026 )
- IOTS -7.8% (proposes private offering of convertible senior notes due 2024)
- ZYNE -5.2% (announces "positive" top line results from the open label Phase 2 BELIEVE 1 clinical trial)
- CTST -3.9% (extending move lower after announcing Health Canada suspended its license)
- ACAD -3.5% (prices underwritten public offering of 6.25 mln shares of its common stock at a price to the public of $40.00 per share)
- CBAY -3.4% (announces departure of Chief Medical Officer Pol Boudes, M.D.)
- UPS -3.1% (following FDX earnings/guidance)
- WLL -1.8% (extending yesterday's 16% move lower)
- ALXN -1.3% (announces CFO transition; Paul Clancy to be succeeded by Aradhana Sarin, M.D. after filing of Q3 results)
Analyst comments:
- N/A.
Gapping up
In reaction to strong earnings/guidance:
- N/A.
Other news:
- CDW +6.4% (to join S&P 500), TLRD +2.9% (President/CEO and Director each disclosed the purchase of 15K)
- ROAD +2.8% (prices secondary offering of 5 mln shares of its Class A common stock by certain shareholders at $14.25 per share )
- BE +2.7% (after closing more than 20% lower on cautious newsletter report)
- PLUG +1.8% (announces 'five-year plan that will position the company to deliver on an annual basis by 2024 $1 billion of revenue')
- LTRPA +1.2% (ticking higher; President/CEO disclosed the purchase of ~15K shares of Series B Common Stock worth ~$160K)
- KDMN +0.8% (announced that the FDA has approved its generic Trientine Hydrochloride Capsules USP, 250 mg)
Analyst comments:
- TELL +1.4% (initiated with Outperform at Evercore ISI; tgt $14)
- AEO +1.1% (initiated with a Buy at DA Davidson)
- CACI +0.8% (added to Conviction Buy list at Goldman)
Early premarket gappersGapping up:
- ZYNE +9.7%, CDW +6.3%, ROAD +3.5%, TLRD +2.4%, LTRPA +1.2%, AEO +1.1%, CACI +0.8%, KDMN +0.8%, TELL +0.8%
Gapping down:
- FDX -11.9%, TBIO -10.4%, IOTS -7.8%, PTCT -7.7%, CHWY -3.9%, ACAD -3.7%, CBAY -3.6%, CTST -3.1%, WLL -3%, UPS -2.7%, ADBE -2.1%, STLD -2%, ALXN -1.3%, INVH -0.9%